Cite
HARVARD Citation
Wald, A. et al. (n.d.). O3-S5.01 Impact of AIC316, a novel antiviral helicase-primase inhibitor, on genital HSV shedding: randomised, double-blind, placebo-controlled trial. Sexually transmitted infections. pp. A78-A79. [Online].